Details

NameSymbolSector
JENBURKT PHARMACEUTICALS LTD.JENBURPHPharmaceuticals
Open
1157.45
High
1183.95
Low
1117.5
Close
1180
Volume
1638
Exchange
bse
Time
14/08

Outlook

Score:  

3.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Jenburkt Pharmaceuticals is  
Three Inside Up
Estimated Stoploss of Jenburkt Pharmaceuticals is ₹  
1082.1
Jenburkt Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Three Inside Up
 candle pattern indicates Jenburkt Pharmaceuticals has chances of  
Reversalℹ
 to up trend 

Trend

Jenburkt Pharmaceuticals is in  
Downtrendℹ
. 
Price of Jenburkt Pharmaceuticals is  
Downℹ
 by  

8.36

%. 
Target
Buy @ 

1143

Sell @ 

1339.85

Volume

The trade volumes of Jenburkt Pharmaceuticals have been  
Underperformingℹ
The volume trend for Jenburkt Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Jenburkt Pharmaceuticals is  

Down

 by  

2.24

% 

Valuation

The current market price of Jenburkt Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
The balance sheet of Jenburkt Pharmaceuticals is:  

Balanced

Cashflow
Jenburkt Pharmaceuticals has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 3cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

52.94% i.e. ₹ 27cr earned in operatingℹ
33.33% i.e. ₹ 17cr spent in investingℹ
13.73% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Jenburkt Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

53.33% i.e. ₹ 8cr earned in operatingℹ
0% in investingℹ
46.67% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Income
The income of Jenburkt Pharmaceuticals is  

₹ 37cr

 and  

Profit

 is :  

₹ 7cr

(*Jun 2025)

Jenburkt Pharmaceuticals Profit is down by:  

12.5

% and Income is Down by:  

11.9

% 

(*Jun 2025)

The income of Jenburkt Pharmaceuticals is  

₹ 42cr

 and  

Profit

 is :  

₹ 8cr

(*Mar 2025)

Jenburkt Pharmaceuticals Profit is up by:  

33.33

% and Income is Up by:  

10.53

% 

(*Mar 2025)

The income of Jenburkt Pharmaceuticals is  

₹ 38cr

 and  

Profit

 is :  

₹ 6cr

(*Dec 2024)

Jenburkt Pharmaceuticals Profit is down by:  

33.33

% and Income is Down by:  

11.63

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.